These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18037591)

  • 1. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.
    Park JY; Zheng W; Kim D; Cheng JQ; Kumar N; Ahmad N; Pow-Sang J
    Cancer Detect Prev; 2007; 31(5):359-65. PubMed ID: 18037591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer.
    Park JY; Helm JF; Zheng W; Ly QP; Hodul PJ; Centeno BA; Malafa MP
    Pancreas; 2008 May; 36(4):e32-9. PubMed ID: 18437076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer.
    Park JY; Kim D; Yang M; Park HY; Lee SH; Rincon M; Kreahling J; Plass C; Smiraglia DJ; Tockman MS; Kim SJ
    Lung Cancer; 2013 Mar; 79(3):198-204. PubMed ID: 23273563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.
    Ueno M; Toyota M; Akino K; Suzuki H; Kusano M; Satoh A; Mita H; Sasaki Y; Nojima M; Yanagihara K; Hinoda Y; Tokino T; Imai K
    Tumour Biol; 2004; 25(3):134-40. PubMed ID: 15361710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
    Li H; Myeroff L; Smiraglia D; Romero MF; Pretlow TP; Kasturi L; Lutterbaugh J; Rerko RM; Casey G; Issa JP; Willis J; Willson JK; Plass C; Markowitz SD
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8412-7. PubMed ID: 12829793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
    Vinarskaja A; Schulz WA; Ingenwerth M; Hader C; Arsov C
    Urol Oncol; 2013 Jul; 31(5):622-7. PubMed ID: 21803613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
    Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
    Hernández-Juárez J; Vargas-Sierra O; Herrera LA; Cantú De León D; Fernández-Retana J; Pérez-Plasencia C; López-Camarillo C; Gariglio P; Díaz-Chávez J
    Int J Oncol; 2019 May; 54(5):1613-1624. PubMed ID: 30896789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the human SLC5A8 gene promoter.
    Zhang Y; Bao YL; Wu Y; Yu CL; Sun Y; Li YX
    Cancer Genet Cytogenet; 2010 Jan; 196(2):124-32. PubMed ID: 20082847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas.
    Porra V; Ferraro-Peyret C; Durand C; Selmi-Ruby S; Giroud H; Berger-Dutrieux N; Decaussin M; Peix JL; Bournaud C; Orgiazzi J; Borson-Chazot F; Dante R; Rousset B
    J Clin Endocrinol Metab; 2005 May; 90(5):3028-35. PubMed ID: 15687339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.
    Lin HY; Park HY; Radlein S; Mahajan NP; Sellers TA; Zachariah B; Pow-Sang J; Coppola D; Ganapathy V; Park JY
    Urology; 2011 Oct; 78(4):971.e1-9. PubMed ID: 21802122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
    Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
    Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors.
    Pulukuri SM; Patibandla S; Patel J; Estes N; Rao JS
    Oncogene; 2007 Aug; 26(36):5229-37. PubMed ID: 17325663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases.
    Thangaraju M; Gopal E; Martin PM; Ananth S; Smith SB; Prasad PD; Sterneck E; Ganapathy V
    Cancer Res; 2006 Dec; 66(24):11560-4. PubMed ID: 17178845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells.
    Zhang Y; Bao YL; Yang MT; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1964-72. PubMed ID: 20732443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.